Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Marie-Louise Lehmann"'
Publikováno v:
European Journal of Clinical Pharmacology
Purpose Ivabradine has been approved for the treatment of chronic heart failure and chronic stable angina pectoris in Europe. Based on adverse outcomes of reproductive animal studies and the lack of human data, ivabradine is considered contraindicate
Autor:
Walter E. Haefeli, Gerd Mikus, Marlene Schaumaeker, Jürgen Burhenne, Marie-Louise Lehmann, Kathrin I. Foerster
Publikováno v:
British Journal of Clinical Pharmacology
Aims Using 3 different perpetrators the impact of voriconazole, cobicistat and rifampicin (single dose), we evaluated the suitability of a microdose cocktail of factor Xa inhibitors (FXaI; rivaroxaban, apixaban and edoxaban; 100 μg in total) to stud
Autor:
Antonia Brings, David Czock, Marie-Louise Lehmann, Johanna Weiss, Kathrin I. Foerster, Walter E. Haefeli, Jürgen Burhenne
Publikováno v:
Br J Clin Pharmacol
Aims Rivaroxaban exposure is considerably increased by drugs that are combined P-glycoprotein (P-gp) and strong cytochrome P450 (CYP) 3A inhibitors (e.g. ketoconazole). The aim of the present study was to investigate the effects of the potent P-gp in
Autor:
Michael Schäper, Stefan Kleinbeck, Klaus Golka, Marlene Pacharra, Marie Louise Lehmann, Christoph van Thriel, Meinolf Blaszkewicz, Thomas Brüning
Publikováno v:
Archives of Toxicology
Archives of toxicology, 94:1687-1701
Archives of toxicology, 94:1687-1701
Sensory irritation is an acute adverse effect caused by chemicals that stimulate chemoreceptors of the upper respiratory tract or the mucous membranes of the outer eye. The avoidance of this end point is of uttermost importance in regulatory toxicolo
Autor:
Kathrin I. Foerster, Gerd Mikus, Walter E. Haefeli, Marie-Louise Lehmann, Marlene Schaumaeker
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO2-14
Autor:
Alexander Kress, Jan G. Hengstler, Klaus Golka, Marie-Louise Lehmann, Michael C. Truss, Meinolf Blaszkewicz, Christoph Kuhn, Matthias Hermes
Publikováno v:
Journal of Toxicology and Environmental Health, Part A. 80:411-416
The gold standard of saving fresh tissue in liquid nitrogen has some serious disadvantages in that this process is not available in daily medical routine practices even in many tumor centers. Our approach of a new minimally invasive technique is obta
Autor:
Michael Schäper, Stefan Kleinbeck, Marie-Louise Lehmann, Klaus Golka, Stephanie A. Juran, Meinolf Blaszkewicz, Kathrin Hey, Marlene Pacharra, Christoph van Thriel
Publikováno v:
Journal of Toxicology and Environmental Health, Part A. 79:1026-1040
Perceptions that arise from stimulation of olfactory and trigeminal receptors in the nasal cavity guide the evaluation of chemical environment in humans. Strong interindividual differences in these assessments may be attributed to nonsensory factors
Autor:
Walter E. Haefeli, Marie-Louise Lehmann, Gerd Mikus, Jürgen Burhenne, Marlene Schaumaeker, Kathrin I. Foerster
Publikováno v:
Clinical pharmacokinetics. 58(9)
The aim of this study was to prove the suitability of simultaneously administered microdoses of the factor Xa inhibitors (FXaIs) rivaroxaban, apixaban and edoxaban (100 µg in total). To evaluate drug–drug interactions, the impact of ketoconazole,
Autor:
Anna Maria Paul, Alessandro Serretti, Olga Efimkina, Julia C. Stingl, Michael Steffens, David Gurwitz, Chiara Fabbri, Eva Ersfeld, Marcus Ising, Susanne Lucae, Catharina Scholl, Concetta Crisafulli, Kristina Probst-Schendzielorz, Roberto Viviani, Marco Calabrò, Marie-Louise Lehmann, Florian Holsboer
Publikováno v:
Pharmacogenomics. 16:689-701
Aim: The identification of antidepressant drugs (ADs) response biomarkers in depression is of high clinical importance. We explored CHL1 and ITGB3 expression as tentative response biomarkers. Materials & methods: In vitro sensitivity to ADs, as well
Publikováno v:
British Journal of Clinical Pharmacology. 77:684-694
Because of the large variation in the response to psychoactive medication, many studies have attempted to uncover genetic factors that determine response. While considerable knowledge exists on the large effects of genetic polymorphisms on pharmacoki